Global private equity and venture capital news and research

Posts Tagged ‘KKR’

1 September 2016

KKR’s Pillarstone brings in new COO

3fcaedf Pillarstone, which was set up by US buyout house KKR last year, has expanded its team with the hire of Paul Bramley as chief operating officer.

30 August 2016

KKR reshuffles Asia Pacific leadership ahead of new pan-Asian fundraise

lu_ming_web_0_0 KKR is expanding its senior team in Asia Pacific a week after it became known the PE group is gearing up for a new fund focused on the region.

26 August 2016

KKR leads race to buy Entertainment One after ITV withdraws bid

tv television KKR is in a strong position to buy for Entertainment One following ITV's decision to withdraw its bid for the Canadian TV producer.

24 August 2016

KKR looks to expand Southeast Asia presence with Shastry hire

Ashish Global private equity firm KKR is reportedly looking to expand its Southeast Asian business with the hire of Ashish Shastry.

23 August 2016

KKR eyes $6bn-$7bn for new pan-Asian fund

blossom-1346456_640 Private equity heavyweight KKR is reportedly looking to launch its third pan-Asian fund soon, targeting a size between $6bn and $7bn.

15 August 2016

KKR eyeing Entertainment One after TV company rejects ITV bid

remote-control-932273_640 PE major KKR is reportedly looking into a potential bid for Canadian TV producer Entertainment One after the company rejected a £1bn offer from UK's ITV.

11 August 2016

KKR, TPG offload shares in Zimmer Biomet

xray2_lrg KKR and TPG Capital have sold around 7.4 million shares in Zimmer Biomet Holding in a $965m secondary offering.

1 August 2016

PE firms eye bid for Hewlett Packard Enterprise

boy-looking-through-binoculars-819685-m Three private equity firms are reportedly considering buying enterprise technology company Hewlett Packard Enterprise.

28 July 2016

UPDATED – KKR confirms full exit from Gland Pharma to China’s Fosun for $1.26bn

nurse-527621_640 Global private equity group KKR has confirmed the sale of its stake in India's Gland Pharma to Shanghai Fosun Pharmaceutical Group for $1.26bn.

27 July 2016

KKR’s North America XII looks at impressive $13bn final close in H2 2016

packs-163497_640 Global private equity group KKR expects to wrap up its latest North American fund in the second half of this year at eye-watering $13bn, according to senior exec Scott Nuttall.

Page 3 of 6812345...102030...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016